Hippocampal Availability of the α7 Nicotinic Acetylcholine Receptor in Recent-Onset Psychosis
Wong NR, Rubin LH, Harrington CK, Jenkins KR, Shinehouse LK, Yoon M, Kilgore JJ, Soule AR, Lesniak WG, Rowe SP, Horti AG, Kamath V, Dannals RF, Du Y, Pomper MG, Coughlin JM
2024
[18F]FNDP PET Neuroimaging Test-Retest Repeatability and Whole Body Dosimetry in Humans
Du Y, Coughlin JM, Amindarolzarbi A, Sweeney SE, Harrington CK, Brosnan MK, Zandi A, Shinehouse LK, Reyes Sanchez AN, Abdallah R, Holt DP, Fan H, Lesniak WG, Nandi A, Rowe SP, Solnes LB, Dannals RF, Horti AG, Lodge MA, Pomper MG
2023
Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV
Rubin LH, Du Y, Sweeney SE, OToole R, Harrington CK, Jenkins K, Lesniak WG, Veenhuis RT, Dastgheyb R, Severson J, Fan H, Holt DP, Hall AW, Dannals RF, Horti AG, Pomper MG, Coughlin JM
2023
First in Human Imaging Using [11C]MDTC, A Radiotracer Targeting the Cannabinoid Receptor Type 2
Du Y, Coughlin JM, Brosnan MK, Chen A, Shinehouse LK, Abdallah R, Lodge MA, Mathews WB, Liu C, Wu Y, Minn I, Finley P, Hall AW, Lesniak WG, Dannals RF, Horti AG, Pomper MG
2023
First-in-human use of [11C]CPPC with positron emission tomography for imaging the macrophage colony stimulating factor 1 receptor
Coughlin JM, Du Y, Lesniak WG, Harrington CK, Brosnan MK, OToole R, Zandi A, Sweeney SE, Abdallah R, Wu Y, Holt DP, Hall AW, Dannals RF, Solnes L, Horti AG, Pomper MG
2022
First-in-human neuroimaging of soluble epoxide hydrolase using [18F]FNDP PET
Coughlin JM, Slania S, Du Y, Shinehouse LK, Brosnan MK, Behnam Azad B, Holt DP, Fan H, Lesniak WG, Minn I, Rowe SP, Dannals RF, Horti AG, Pomper MG
2021
A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia
Coughlin JM, Yang K, Marsman A, Pradhan S, Wang M, Ward RE, Bonekamp S, Ambinder EB, Higgs CP, Kim PK, Edwards JA, Varvaris M, Wang H, Posporelis S, Ma S, Tsujimura T, Edden RAE, Pomper MG, Sedlak T, Fournier M, Schretlen DJ, Cascella NG, Barker PB, Sawa A
2021
Assessing Brain Metabolism With 7T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis
Wang AM, Pradhan S, Coughlin JM, Trivedi A, DuBois SL, Crawford JL, Sedlak TW, Nucifora FC Jr, Nestadt G, Nucifora LG, Schretlen DJ, Sawa A, Barker PB
2019
High availability of the α7 nicotinic acetylcholine receptor in brains of individuals with mild cognitive impairment: a pilot study using [18F]ASEM PET
Coughlin JM, Rubin LH, Du Y, Rowe SP, Crawford JL, Rosenthal HB, Frey SM, Marshall ES, Shinehouse LK, Chen A, Speck CL, Wang Y, Lesniak WG, Minn I, Bakker A, Kamath V, Smith GS, Albert MS, Behnam Azad B, Dannals RF, Horti A, Wong DF, Pomper MG
2019
18F-XTRA PET for enhanced imaging of the extrathalamic α4β2 nicotinic acetylcholine receptor
Coughlin JM, Slania S, Du Y, Rosenthal HB, Lesniak WG, Minn I, Smith G, Dannals RF, Kuwabara H, Wong DF, Wang Y, Horti A, Pomper MG
2018
The Distribution of the Alpha7 Nicotinic Acetylcholine Receptor in Healthy Aging: An In Vivo Positron Emission Tomography Study with [18F]ASEM
Coughlin JM, Du Y, Rosenthal HB, Slania S, Koo SM, Park A, Solomon G, Vranesic M, Antonsdottir I, Speck CL, Rootes Murdy K, Lerner A, Rowe SP, Wang Y, Lesniak WG, Minn I, Bakker A, Smith G, Dannals RF, Kuwabara H, Horti A, Wong DF, Pomper MG
2018
Imaging of glial cell activation and white matter integrity in brains of active and recently retired National Football League players
Coughlin, JM , Wang, Y, Minn I, Bienko N, Ambinder EB, Xu X, Peters ME, Dougherty JW, Vranesic M, Koo SM, Ahn H, Lee M, Cottrell C, Sair HI, Sawa A, Munro CA, Nowinski CJ, Dannals RF, Lyketsos CG, Kassiou M, Smith G, Caffo B, Mori S, Guilarte TR, Pomper MG
2017
In vivo markers of inflammatory response in recent onset schizophrenia: A combined study using [11C]DPA-713 PET and analysis of CSF and plasma
Coughlin JM, Wang Y, Ambinder E, Ward R, Minn I, Vranesic M, Kim PK, Ford C, Higgs C, Hayes L, Schretlen D, Dannals RF, Kassiou M, Sawa A, Pomper MG
2016